A Study of NT 201 Doses in the Treatment of Platysma Prominence — PAOLA

Platysma Prominence Clinical Trial

Official title:
A Prospective, Double-blind, Randomized, Placebo-controlled, Multicenter Study to Investigate the Efficacy and Safety of NT 201 Doses in the Treatment of Platysma Prominence

Status Completed

Clinical Trial Summary

The purpose of this study is to assess the safety and efficacy of NT 201 in adults with moderate to severe platysma prominence.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Platysma Prominence

Clinical Trial Details

NCT number	NCT05773053
Study type	Interventional
Source	Merz North America, Inc.
Contact
Status	Completed
Phase	Phase 2
Start date	March 22, 2023
Completion date	January 24, 2024

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT05134649` - A Study To Assess the Safety of OnabotulinumtoxinA (BOTOX) Intramuscular Injection in Adult Participants With Platysma Prominence	Phase 3
Completed	`NCT04949399` - A Study To Assess the Safety and Effects of OnabotulinumtoxinA (BOTOX) Intramuscular Injection in Adult Participants With Moderate to Severe Platysma Prominence	Phase 3
Completed	`NCT04994535` - A Study To Assess the Safety and Effects of OnabotulinumtoxinA (BOTOX) Intramuscular Injection in Adult Participants With Platysma Prominence	Phase 3
Completed	`NCT03915067` - BOTOX® for the Treatment of Platysma Prominence	Phase 2